Dicerna Pharmaceuticals, Inc. (DRNA) Earnings
|
Expand Research on DRNA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -60.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.9% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/21 |  |
Q321 | -$0.22 | -$0.46 | +$0.24 | $63M | $43.78M | N/A |  | | Details |
| 8/9/21 | |
Q221 | -$0.53 | $0.41 | -$0.94 | $41.3M | $91.29M | N/A | | | Details |
| 5/6/21 | |
Q121 | -$0.39 | -$0.37 | -$0.02 | $47.6M | $46.28M | N/A | | | Details |
2/25/21  |
|
Q420 | N/A | -$0.03 | N/A | N/A | $67.25M | N/A | N/A | N/A | |
| 11/5/20 |
|
Q320 | N/A | -$0.20 | N/A | N/A | $51.5M | N/A | N/A | N/A | |
| 5/7/20 |
|
Q120 | N/A | $0.27 | N/A | N/A | $59.83M | N/A | N/A | N/A | |
| 2/27/20 | |
Q419 | -$0.58 | N/A | N/A | $7.08M | $1.54M | N/A | | | Details |
| 11/7/19 | |
Q319 | -$0.45 | -$0.28 | -$0.17 | $8.04M | $11.06M | N/A | | | Details |
